Shares of IOL Chemicals and Pharmaceuticals Ltd. jumped 3.49% to ₹98.42 on the NSE in Monday’s session following the company’s strong Q1 FY26 earnings. The stock rose from its previous close of ₹95.10, adding over ₹950 crore to its market capitalization, which now stands at ₹28,790 crore.
The rally was driven by the company’s better-than-expected financial performance for the quarter ended June 30, 2025. Net profit rose 13.3% year-on-year to ₹34 crore, compared to ₹30 crore in Q1 FY25.
Revenue for the quarter increased 10% to ₹552 crore, from ₹502 crore in the corresponding period last year. Strong performance across the active pharmaceutical ingredients (API) and specialty chemicals segments contributed to the top-line growth.
EBITDA rose 22.5% to ₹63 crore from ₹51 crore YoY, while EBITDA margin improved to 11.4% from 10.2%, reflecting operational efficiencies and improved product mix.
The stock traded in a range of ₹92.64 to ₹98.50 intraday and saw a strong surge in the second half of the trading session, supported by high volume activity of over 2.29 million shares.
With a P/E ratio of 28.46 and a 52-week range of ₹57.50 to ₹107.54, the stock continues to attract investor interest on improving fundamentals and steady growth outlook.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
